Responses
Clinical and epidemiological research
Extended report
Efficacy of prednisone 1–4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.